IL97677A - Method for recovering fetal cells from a blood sample containing a mixed population of maternal and fetal cells - Google Patents
Method for recovering fetal cells from a blood sample containing a mixed population of maternal and fetal cellsInfo
- Publication number
- IL97677A IL97677A IL9767791A IL9767791A IL97677A IL 97677 A IL97677 A IL 97677A IL 9767791 A IL9767791 A IL 9767791A IL 9767791 A IL9767791 A IL 9767791A IL 97677 A IL97677 A IL 97677A
- Authority
- IL
- Israel
- Prior art keywords
- cells
- antibody
- maternal
- fetal
- labeled
- Prior art date
Links
- 230000008774 maternal effect Effects 0.000 title claims abstract description 155
- 230000001605 fetal effect Effects 0.000 title claims abstract description 149
- 238000000034 method Methods 0.000 title claims abstract description 147
- 210000004369 blood Anatomy 0.000 title claims abstract description 53
- 239000008280 blood Substances 0.000 title claims abstract description 52
- 239000000427 antigen Substances 0.000 claims abstract description 112
- 108091007433 antigens Proteins 0.000 claims abstract description 112
- 102000036639 antigens Human genes 0.000 claims abstract description 112
- 108700028369 Alleles Proteins 0.000 claims abstract description 98
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims abstract description 22
- 230000027455 binding Effects 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims description 494
- 239000011324 bead Substances 0.000 claims description 53
- 239000007790 solid phase Substances 0.000 claims description 49
- 230000002068 genetic effect Effects 0.000 claims description 29
- 238000004458 analytical method Methods 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 22
- 101710160107 Outer membrane protein A Proteins 0.000 claims description 18
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 16
- 210000003743 erythrocyte Anatomy 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 5
- 230000000405 serological effect Effects 0.000 claims description 4
- 239000000815 hypotonic solution Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000007850 fluorescent dye Substances 0.000 abstract description 5
- 230000004544 DNA amplification Effects 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 63
- 238000000926 separation method Methods 0.000 description 56
- 210000003754 fetus Anatomy 0.000 description 44
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 32
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 22
- 239000002609 medium Substances 0.000 description 22
- 238000011534 incubation Methods 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 19
- 239000000725 suspension Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 18
- 229960002685 biotin Drugs 0.000 description 17
- 239000011616 biotin Substances 0.000 description 17
- 235000020958 biotin Nutrition 0.000 description 16
- 238000002372 labelling Methods 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 238000010790 dilution Methods 0.000 description 14
- 239000012895 dilution Substances 0.000 description 14
- 238000000684 flow cytometry Methods 0.000 description 14
- 239000000872 buffer Substances 0.000 description 12
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 12
- 108010004729 Phycoerythrin Proteins 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 230000021615 conjugation Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000009257 reactivity Effects 0.000 description 9
- 239000003104 tissue culture media Substances 0.000 description 9
- 230000008775 paternal effect Effects 0.000 description 8
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 8
- 238000005191 phase separation Methods 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 102000054766 genetic haplotypes Human genes 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 210000002593 Y chromosome Anatomy 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000031864 metaphase Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000002669 amniocentesis Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 238000007413 biotinylation Methods 0.000 description 3
- 230000006287 biotinylation Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000004163 cytometry Methods 0.000 description 3
- 239000012470 diluted sample Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 102000025850 HLA-A2 Antigen Human genes 0.000 description 2
- 108010074032 HLA-A2 Antigen Proteins 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 108010004469 allophycocyanin Proteins 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 210000004381 amniotic fluid Anatomy 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 239000003855 balanced salt solution Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000004252 chorionic villi Anatomy 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000000267 erythroid cell Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000011527 multiparameter analysis Methods 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 210000002993 trophoblast Anatomy 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- XYJODUBPWNZLML-UHFFFAOYSA-N 5-ethyl-6-phenyl-6h-phenanthridine-3,8-diamine Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2N(CC)C1C1=CC=CC=C1 XYJODUBPWNZLML-UHFFFAOYSA-N 0.000 description 1
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 1
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 1
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010044495 Fetal Hemoglobin Proteins 0.000 description 1
- 208000022471 Fetal disease Diseases 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- -1 as stated previously Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 210000003783 haploid cell Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/499,932 US5153117A (en) | 1990-03-27 | 1990-03-27 | Fetal cell recovery method |
Publications (2)
Publication Number | Publication Date |
---|---|
IL97677A0 IL97677A0 (en) | 1992-06-21 |
IL97677A true IL97677A (en) | 1996-07-23 |
Family
ID=23987348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9767791A IL97677A (en) | 1990-03-27 | 1991-03-26 | Method for recovering fetal cells from a blood sample containing a mixed population of maternal and fetal cells |
Country Status (16)
Country | Link |
---|---|
US (2) | US5153117A (fr) |
EP (1) | EP0521909B1 (fr) |
JP (1) | JP2965699B2 (fr) |
AT (1) | ATE194166T1 (fr) |
AU (1) | AU649027B2 (fr) |
CA (1) | CA2059554C (fr) |
DE (1) | DE69132269T2 (fr) |
DK (1) | DK0521909T3 (fr) |
ES (1) | ES2149760T3 (fr) |
GR (1) | GR3034487T3 (fr) |
IE (1) | IE910996A1 (fr) |
IL (1) | IL97677A (fr) |
NZ (1) | NZ237589A (fr) |
SG (1) | SG79188A1 (fr) |
WO (1) | WO1991014768A1 (fr) |
ZA (1) | ZA912317B (fr) |
Families Citing this family (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU658132B2 (en) * | 1989-11-13 | 1995-04-06 | Children's Medical Center Corporation | Non-invasive method for isolation and detection of fetal DNA |
US5153117A (en) * | 1990-03-27 | 1992-10-06 | Genetype A.G. | Fetal cell recovery method |
US5627029A (en) * | 1991-05-03 | 1997-05-06 | Genzyme Corporation | Method for obtaining informative cells |
EP0635067A1 (fr) * | 1992-04-09 | 1995-01-25 | Ig Laboratories Inc. | Sondes pour detecter les aneuplo dies chromosomiques courantes d'enfants nes vivants |
US5629147A (en) * | 1992-07-17 | 1997-05-13 | Aprogenex, Inc. | Enriching and identifying fetal cells in maternal blood for in situ hybridization |
JPH07509136A (ja) * | 1992-07-17 | 1995-10-12 | バイシス,インク. | インサイチュ(in situ)・ハイブリダイゼーションのための母体血液中の胎児細胞の富化と同定 |
US5275933A (en) * | 1992-09-25 | 1994-01-04 | The Board Of Trustees Of The Leland Stanford Junior University | Triple gradient process for recovering nucleated fetal cells from maternal blood |
CA2153257A1 (fr) * | 1993-01-06 | 1994-07-21 | Terry J. Fetterhoff | Detection par fluorescence de cellules non viables |
US5457024A (en) * | 1993-01-22 | 1995-10-10 | Aprogenex, Inc. | Isolation of fetal erythrocytes |
AU7921194A (en) * | 1993-09-27 | 1995-04-18 | Oncor, Inc. | Methods for detecting and analyzing individual rare cells in a population |
US5352613A (en) * | 1993-10-07 | 1994-10-04 | Tafas Triantafillos P | Cytological screening method |
US6136540A (en) | 1994-10-03 | 2000-10-24 | Ikonisys Inc. | Automated fluorescence in situ hybridization detection of genetic abnormalities |
GB9422504D0 (en) * | 1994-11-08 | 1995-01-04 | Robertson Patricia M B | Blood testing |
US5750339A (en) * | 1994-11-30 | 1998-05-12 | Thomas Jefferson University | Methods for identifying fetal cells |
US5639669A (en) * | 1995-06-07 | 1997-06-17 | Ledley; Robert | Separation of fetal cells from maternal blood |
US5962237A (en) * | 1996-04-05 | 1999-10-05 | The Johns Hopkins University School Of Medicine | Method of enriching rare cells |
US6060240A (en) * | 1996-12-13 | 2000-05-09 | Arcaris, Inc. | Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom |
DE69830598T2 (de) | 1997-01-31 | 2006-05-18 | The Horticulture And Food Research Institute Of New Zealand Limited | Optische vorrichtung und methode |
CN1260046A (zh) * | 1997-03-08 | 2000-07-12 | 邓迪大学 | 出生前诊断法 |
US6890755B1 (en) * | 1997-12-08 | 2005-05-10 | The Trustees Of Columbia University In The City Of New York | Recovery of fetal cells from maternal blood using chaotic advection |
US6149867A (en) | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
US6210889B1 (en) * | 1998-01-28 | 2001-04-03 | The Universite Laval | Method for enrichment of fetal cells from maternal blood and use of same in determination of fetal sex and detection of chromosomal abnormalities |
US6733967B1 (en) | 1998-04-21 | 2004-05-11 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
BR9912539A (pt) | 1998-07-30 | 2001-05-02 | Xy Inc | Sistema equino para inseminação artificial não-cirúrgica |
EP1163502A1 (fr) * | 1999-02-18 | 2001-12-19 | Bio-View Ltd | Systeme et procede d'identification et d'analyse de types de cellules rares dans une population melangee de cellules |
WO2000071987A2 (fr) * | 1999-05-25 | 2000-11-30 | John Philip | Isolation et culture de cellules embryonnaires |
EP1283904A2 (fr) * | 1999-11-03 | 2003-02-19 | Oncotech, Inc. | Methodes de prognostic et de diagnostic du cancer |
US7208265B1 (en) | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
AU2001277635A1 (en) * | 2000-03-14 | 2001-10-08 | Exiqon A/S | New methods for separation and isolation of subpopulations of cells in biological samples |
EP2258172B1 (fr) | 2000-05-09 | 2017-04-19 | Xy, Llc | Cytométre de flux pour différencier des populations de spermatozoïdes portant un chromosome X et un chromosome Y |
BRPI0115791B1 (pt) | 2000-11-29 | 2020-05-05 | Colorado State Univ | sistema para fertilização in vitro com espematozóides separados em populações portadoras de cromossoma x e cromossoma y |
US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
EP1405058A4 (fr) * | 2001-03-19 | 2007-07-04 | Ikonisys Inc | Systeme et procede pour accentuer le contraste d'une image produite par un microscope a epifluorescence |
US20040214314A1 (en) * | 2001-11-02 | 2004-10-28 | Friedrich Srienc | High throughput bioreactor |
EP1451304A4 (fr) * | 2001-11-07 | 2006-09-20 | Bioview Ltd | Kits et methodes de preparation d'echantillons cellulaires optimises pour une coloration duale |
US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
CA2477761A1 (fr) * | 2002-03-01 | 2003-09-12 | Ravgen, Inc. | Procedes de detection de troubles genetiques |
US20070178478A1 (en) * | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
CA2492631C (fr) * | 2002-05-31 | 2013-03-12 | Genetic Technologies Limited | Anticorps maternels servant de marqueurs de cellules foetales permettant d'identifier et d'enrichir les cellules foetales du sang maternel |
JPWO2003104806A1 (ja) * | 2002-06-07 | 2005-10-06 | 東和科学株式会社 | 検出キット、それに用いられる測定プレート、検出方法、評価方法、カエルビテロジェニンのポリクローナル抗体及びその製造方法 |
AU2003243475A1 (en) * | 2002-06-13 | 2003-12-31 | New York University | Early noninvasive prenatal test for aneuploidies and heritable conditions |
EP1545203B1 (fr) | 2002-08-01 | 2016-10-19 | Xy, Llc | Systeme de separation de cellules spermatiques basse pression |
US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
WO2004017041A2 (fr) | 2002-08-15 | 2004-02-26 | Xy, Inc. | Cytometre de flux a haute resolution |
US7169548B2 (en) | 2002-09-13 | 2007-01-30 | Xy, Inc. | Sperm cell processing and preservation systems |
EP2359689B1 (fr) | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Dispositif microfluidique pour la séparation de cellules et usage du dispositif |
DK1816461T3 (da) | 2002-10-16 | 2020-04-14 | Streck Laboratories Inc | Fremgangsmåde og indretning til indsamling og sikring af celler til brug for analyse |
US8394582B2 (en) * | 2003-03-05 | 2013-03-12 | Genetic Technologies, Inc | Identification of fetal DNA and fetal cell markers in maternal plasma or serum |
EP2305172B1 (fr) | 2003-03-28 | 2016-05-11 | Inguran, LLC | Appareil et procédés pour fournir du sperme d'animaux triés selon le sexe |
CA2566749C (fr) | 2003-05-15 | 2017-02-21 | Xy, Inc. | Tri efficace de cellules haploides pour systemes de cytometrie en flux |
EP2151243B1 (fr) | 2004-03-29 | 2012-10-24 | Inguran, LLC | Suspensions de sperme pour trier des populations enrichies contenant les chromosomes X ou Y |
WO2006012597A2 (fr) | 2004-07-22 | 2006-02-02 | Monsanto Technology Llc | Procede pour enrichir une population de spermatozoides |
US7527978B2 (en) * | 2004-10-07 | 2009-05-05 | Children's Hospital & Research Center At Oakland | Flow cytometry based micronucleus assays and kits |
US7439062B2 (en) * | 2004-12-23 | 2008-10-21 | Biocept, Inc. | Beads for capturing target cells from bodily fluid |
GB2427468B (en) * | 2005-04-05 | 2011-03-02 | Cellpoint Diagnostics | Cell separation device and method for the detection of EpCAM positive cells |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
GB0509500D0 (en) * | 2005-05-10 | 2005-06-15 | Revealcyte | Method of fetal cell enrichment |
EP1886138A4 (fr) * | 2005-05-11 | 2009-04-15 | Genetic Technologies Ltd | Procédés d'enrichissement de cellules fétales |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
CA2632859C (fr) * | 2005-12-02 | 2014-07-15 | Simons Haplomics Limited | Procedes de cartographie genetique et d'haplotypage |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
EP2589668A1 (fr) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Analyse de cellules rares utilisant la division d'échantillons et les marqueurs d'ADN |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
GB0616045D0 (en) * | 2006-08-11 | 2006-09-20 | Univ Bristol | Blood cell separation |
DE102006062619B4 (de) * | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Verfahren zur Bestimmung von minoren Zellpopulationen in heterogenen Zellpopulationen |
EP2250497B1 (fr) * | 2008-02-18 | 2014-09-10 | Genetic Technologies Limited | Procedes de traitement et/ou d'enrichissement de cellules |
US20120149587A1 (en) * | 2008-03-12 | 2012-06-14 | University Of Virginia Patent Foundation | Method for detecting nucleated cells |
WO2009114709A2 (fr) | 2008-03-12 | 2009-09-17 | Uva Patent Foundation | Détection d’analytes polymères |
ES2620431T3 (es) | 2008-08-04 | 2017-06-28 | Natera, Inc. | Métodos para la determinación de alelos y de ploidía |
CA3069082C (fr) | 2008-09-20 | 2022-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic non effractif d'aneuploidie foetale par sequencage |
US20100167271A1 (en) * | 2008-12-30 | 2010-07-01 | Streck, Inc. | Method for screening blood using a preservative that may be in a substantially solid state form |
US11634747B2 (en) * | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
DE202010018561U1 (de) | 2009-01-21 | 2017-08-28 | Streck Inc. | Blutsammelröhrchen |
US8304187B2 (en) | 2009-02-18 | 2012-11-06 | Streck, Inc. | Preservation of cell-free RNA in blood samples |
WO2010121294A1 (fr) | 2009-04-21 | 2010-10-28 | Genetic Technologies Limited | Procédés d'obtention de matériel génétique foetal |
US20120185176A1 (en) | 2009-09-30 | 2012-07-19 | Natera, Inc. | Methods for Non-Invasive Prenatal Ploidy Calling |
EP2499259B1 (fr) * | 2009-11-09 | 2016-04-06 | Streck Inc. | Stabilisation d'arn et extraction d'arn présent dans des cellules intactes d'un échantillon sanguin |
US8774488B2 (en) | 2010-03-11 | 2014-07-08 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA3037126C (fr) | 2010-05-18 | 2023-09-12 | Natera, Inc. | Procedes de classification de ploidie prenatale non invasive |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
JP6328934B2 (ja) | 2010-12-22 | 2018-05-23 | ナテラ, インコーポレイテッド | 非侵襲性出生前親子鑑定法 |
JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ, インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
US9956281B2 (en) | 2011-05-04 | 2018-05-01 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
CA2917912C (fr) | 2013-07-24 | 2019-09-17 | Streck, Inc. | Compositions et methodes de stabilisation de cellules tumorales circulantes |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
EP3134541B1 (fr) | 2014-04-21 | 2020-08-19 | Natera, Inc. | Détection des ploïdies dans des segments chromosomiques en cancer |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
WO2016183106A1 (fr) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Procédés et compositions pour la détermination de la ploïdie |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
WO2018022991A1 (fr) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Composition de suspension pour contrôle d'analyse hématologique |
WO2018067517A1 (fr) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Procédés pour caractériser une variation de nombre de copies à l'aide d'un séquençage de ligature de proximité |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675286A (en) * | 1985-01-28 | 1987-06-23 | Aspen Diagnostics, Inc. | Fetal cell separation and testing |
US4835098A (en) * | 1985-09-04 | 1989-05-30 | Regents Of University Of Minnesota | Characterization of HLA alleles with locus-specific DNA probes |
US4987086A (en) * | 1987-11-30 | 1991-01-22 | Becton, Dickinson And Company | Method for analysis of subpopulations of cells |
WO1990006509A1 (fr) * | 1988-12-06 | 1990-06-14 | Flinders Technologies Pty. Ltd. | Procede servant a isoler des cellules f×tales du sang maternel en vue d'un diagnostic prenatal |
US5153117A (en) * | 1990-03-27 | 1992-10-06 | Genetype A.G. | Fetal cell recovery method |
-
1990
- 1990-03-27 US US07/499,932 patent/US5153117A/en not_active Expired - Fee Related
-
1991
- 1991-03-26 IL IL9767791A patent/IL97677A/en not_active IP Right Cessation
- 1991-03-26 NZ NZ237589A patent/NZ237589A/en unknown
- 1991-03-26 IE IE099691A patent/IE910996A1/en not_active IP Right Cessation
- 1991-03-27 WO PCT/AU1991/000115 patent/WO1991014768A1/fr active IP Right Grant
- 1991-03-27 ES ES91906073T patent/ES2149760T3/es not_active Expired - Lifetime
- 1991-03-27 AU AU74716/91A patent/AU649027B2/en not_active Expired
- 1991-03-27 JP JP3505625A patent/JP2965699B2/ja not_active Expired - Lifetime
- 1991-03-27 DE DE69132269T patent/DE69132269T2/de not_active Expired - Lifetime
- 1991-03-27 CA CA002059554A patent/CA2059554C/fr not_active Expired - Lifetime
- 1991-03-27 US US07/927,313 patent/US5447842A/en not_active Expired - Lifetime
- 1991-03-27 EP EP91906073A patent/EP0521909B1/fr not_active Expired - Lifetime
- 1991-03-27 ZA ZA912317A patent/ZA912317B/xx unknown
- 1991-03-27 DK DK91906073T patent/DK0521909T3/da active
- 1991-03-27 SG SG9607782A patent/SG79188A1/en unknown
- 1991-03-27 AT AT91906073T patent/ATE194166T1/de not_active IP Right Cessation
-
2000
- 2000-09-26 GR GR20000402176T patent/GR3034487T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2059554A1 (fr) | 1991-09-28 |
EP0521909A4 (en) | 1993-11-18 |
CA2059554C (fr) | 2004-06-22 |
DK0521909T3 (da) | 2000-10-30 |
IE910996A1 (en) | 1991-10-09 |
WO1991014768A1 (fr) | 1991-10-03 |
ATE194166T1 (de) | 2000-07-15 |
JPH05506144A (ja) | 1993-09-16 |
AU649027B2 (en) | 1994-05-12 |
EP0521909B1 (fr) | 2000-06-28 |
ES2149760T3 (es) | 2000-11-16 |
ZA912317B (en) | 1991-12-24 |
JP2965699B2 (ja) | 1999-10-18 |
DE69132269D1 (de) | 2000-08-03 |
EP0521909A1 (fr) | 1993-01-13 |
IL97677A0 (en) | 1992-06-21 |
AU7471691A (en) | 1991-10-21 |
US5153117A (en) | 1992-10-06 |
NZ237589A (en) | 1992-04-28 |
SG79188A1 (en) | 2001-03-20 |
GR3034487T3 (en) | 2000-12-29 |
DE69132269T2 (de) | 2001-03-15 |
US5447842A (en) | 1995-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5447842A (en) | Fetal cell recovery method | |
Bianchi et al. | Erythroid‐specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood | |
US5437987A (en) | Triple gradient process with antibody panning to recover nucleated fetal cells from maternal blood | |
US5714325A (en) | Prenatal diagnosis by isolation of fetal granulocytes from maternal blood | |
EP0500727B1 (fr) | Procede non envahissant d'isolation et de detection d'adn f tal | |
EP1007965B1 (fr) | Utilisation d'anticorps diriges contre l'hemoglobine embryonnaire pour identifier des cellules foetales | |
US5374531A (en) | Immunoassay for determination of cells | |
US5962234A (en) | Use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells | |
US5385822A (en) | Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population | |
US5270169A (en) | Detection of HLA antigen-containing immune complexes | |
US6872541B2 (en) | Method and compositions for analysis of pentraxin receptors as indicators of disease | |
US20090081689A1 (en) | Reagents and methods to enrich rare cells from body fluids | |
WO1994025873A1 (fr) | Procedes d'enrichissement de cellules souches f×tales provenant du sang maternel | |
AU691040B2 (en) | Enrichment of fetal cells from maternal blood | |
US4797475A (en) | Method and composition for isolating white cell elements | |
EP0127358B1 (fr) | Méthode et composition pour isoler les éléments des globules blancs | |
AU7735201A (en) | Fetal cell recovery method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |